Parkin promotes proteasomal degradation of misregulated BAX

J Cell Sci. 2017 Sep 1;130(17):2903-2913. doi: 10.1242/jcs.200162. Epub 2017 Jul 31.

Abstract

The pro-apoptotic BCL-2 protein BAX commits human cells to apoptosis by permeabilizing the outer mitochondrial membrane. BAX activation has been suggested to require the separation of helix α5 from α6 - the 'latch' from the 'core' domain - among other conformational changes. Here, we show that conformational changes in this region impair BAX translocation to the mitochondria and retrotranslocation back into the cytosol, and therefore BAX inhibition, but not activation. Redirecting misregulated BAX to the mitochondria revealed an alternative mechanism of BAX inhibition. The E3 ligase parkin, which is known to trigger mitochondria-specific autophagy, ubiquitylates BAX K128 and targets the pro-apoptotic BCL-2 protein for proteasomal degradation. Retrotranslocation-deficient BAX is completely degraded in a parkin-dependent manner. Although only a minor pool of endogenous BAX escapes retrotranslocation into the cytosol, parkin-dependent targeting of misregulated BAX on the mitochondria provides substantial protection against BAX apoptotic activity.

Keywords: Autophagy; BCL-2 proteins; BCL-xL; Mitochondrial apoptosis; Neuronal cell death.

MeSH terms

  • Apoptosis
  • Cytoprotection
  • HCT116 Cells
  • Humans
  • Lysine / metabolism
  • Mitochondria / metabolism
  • Proteasome Endopeptidase Complex / metabolism*
  • Protein Structure, Secondary
  • Protein Transport
  • Proteolysis*
  • Ubiquitin-Protein Ligases / metabolism*
  • Ubiquitination
  • bcl-2-Associated X Protein / chemistry
  • bcl-2-Associated X Protein / metabolism*

Substances

  • bcl-2-Associated X Protein
  • Ubiquitin-Protein Ligases
  • parkin protein
  • Proteasome Endopeptidase Complex
  • Lysine